According to Zhitong Finance App News, Fangsheng Pharmaceutical (603998.SH) announced that Mr. Zhang Qinghua, the controlling shareholder and actual controller of the company, received the “Administrative Penalty Decision” ([2020] No. 111, [2020] No. 112) issued by the China Securities Regulatory Commission on January 18, 2021 for suspected insider trading of the company's shares. On August 7, 2025, Mr. Zhang Qinghua sent a “Notice Letter” to the company. On August 6, 2025, he received the “Decision to Release Bail Awaiting Trial” (Chang Gongzhi () Withdrawal Letter [2025] 0750) issued by the branch directly under the Changsha Municipal Public Security Bureau. Due to the above matters, it was decided to release him on bail awaiting trial in accordance with relevant laws and regulations. The time limit starts on August 6, 2025.

According to Zhitong Finance App News, Fangsheng Pharmaceutical (603998.SH) announced that Mr. Zhang Qinghua, the controlling shareholder and actual controller of the company, received the “Administrative Penalty Decision” ([2020] No. 111, [2020] No. 112) issued by the China Securities Regulatory Commission on January 18, 2021 for suspected insider trading of the company's shares. On August 7, 2025, Mr. Zhang Qinghua sent a “Notice Letter” to the company. On August 6, 2025, he received the “Decision to Release Bail Awaiting Trial” (Chang Gongzhi () Withdrawal Letter [2025] 0750) issued by the branch directly under the Changsha Municipal Public Security Bureau. Due to the above matters, it was decided to release him on bail awaiting trial in accordance with relevant laws and regulations. The time limit starts on August 6, 2025.